Kang Y et al., about twenty years ago, demonstrated that IL-11 is the most abundantly expressed osteolytic factor in breast cancer cells highly metastatic to bone, and that TGFβ further increases the already high level of IL-11 [85]. This evidence concerns the gene IL11 and breast carcinoma.